NURPF   $8.58  7.25% Market Closed

NEUREN PHARMS LTD ORD
Total Cash 213.17M
totalCashPerShare 1.668
EBITDA 155.19M
Total Debt 0.00
quickRatio 25.423
currentRatio 25.423
Total Revenue 193.34M
debtToEquity
Revenue/Share 1.514
ROA 0.59556
ROE 0.7551
grossProfits
freeCashflow 98.45M
operatingCashflow 119.51M
earningsGrowth -0.83
revenueGrowth -0.613
grossMargins 0.82983
ebitdaMargins 0.80266
operatingMargins 0.16705999
profitMargins 0.60665
enterpriseValue 866.87M
forwardPE 20.609756
floatShares 110.82M
sharesOutstanding 130.07M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.13%
heldPercentInstitutions 0.18%
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue 1.715
Price To Book help_outline 4.93
earningsQuarterlyGrowth -0.83
netIncomeToCommon 117.29M
trailingEps 0.63%
forwardEps 0.41%
enterpriseToEbitda 5.59
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 56
lastUpdated Nov. 7, 2024, 1:29 a.m.